Agilent demonstrates cell analysis solutions for cancer at AACR 2022
By The Science Advisory Board staff writersApril 12, 2022
The company will present the Agilent Magnis next-generation sequencing (NGS) prep system, its automated benchtop solution to improve cell analysis and assays. This system includes an onboard wizard to aid in the fast setup of cell assays in under five minutes. The tool will aid researchers in characterizing samples with high efficiency at reduced costs compared to traditional methods, the company said.
Agilent's second tool is the Agilent XF Pro Analyzer, which can be used for real-time cell analysis and monitoring. This tool also has capabilities for optimized data analysis and interpretation to be applied toward therapeutic drug or biologic development. This capability also allows for improved disease model generation and helps to identify drug targets, Agilent said.